Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men

[1]  K. Bønaa,et al.  Serum total homocysteine and coronary heart disease. , 1995, International journal of epidemiology.

[2]  A. Lindgren,et al.  Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid , 1995, Journal of internal medicine.

[3]  R. D'Agostino,et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.

[4]  M. Stampfer,et al.  Can lowering homocysteine levels reduce cardiovascular risk? , 1995, The New England journal of medicine.

[5]  A. Lindgren,et al.  Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjects , 1994, Journal of internal medicine.

[6]  M. Malinow.  Homocyst(e)ine and arterial occlusive diseases , 1994, Journal of internal medicine.

[7]  P. Ueland,et al.  Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. , 1994, The Journal of nutrition.

[8]  W. Willett,et al.  A Prospective Study of Plasma Homocyst(e)ine and Risk of Ischemic Stroke , 1994, Stroke.

[9]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Salonen,et al.  Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.

[11]  I. Perry,et al.  Haematocrit, hypertension and risk of stroke , 1994 .

[12]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[13]  L. Chambless,et al.  Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. , 1993, Circulation.

[14]  P. Ueland,et al.  Homocysteine and other thiols in plasma and urine: automated determination and sample stability. , 1993, Clinical chemistry.

[15]  J. Stamler,et al.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.

[16]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[17]  R. Francis.  Atherosclerotic cardiovascular disease, hemostasis, and endothelial function , 1992 .

[18]  P. Macfarlane,et al.  Risk factors for stroke in middle aged British men. , 1991, BMJ.

[19]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[20]  P. Ueland,et al.  Fully automated fluorescence assay for determining total homocysteine in plasma. , 1989, Clinical chemistry.

[21]  M. Walker,et al.  Diurnal variations in serum biochemical and haematological measurements. , 1989, Journal of clinical pathology.

[22]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[23]  S. Mudd.  Disorders of transsulfuration , 1989 .

[24]  P. Macfarlane,et al.  Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. , 1985, Journal of epidemiology and community health.

[25]  A. G. Shaper,et al.  Follow-up of subjects in prospective studies based in general practice. , 1984, The Journal of the Royal College of General Practitioners.

[26]  P. Macfarlane,et al.  Prevalence of ischaemic heart disease in middle aged British men. , 1984, British heart journal.

[27]  D. Ashby,et al.  Blood lipids in middle-aged British men. , 1983, British heart journal.

[28]  S J Pocock,et al.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. , 1981, British medical journal.